Laurabolin
Active substance
ATC code
Species
Dogs and cats.
Indications
Nandrolone is a testosterone derivative which can be used in the supportive management of chronic renal failure.
Dose to be administered and administration route
Species Dosage
| Dog | 2-5 mg/kg |
| Cat | 2-5 mg/kg |
As with all hormone therapy there can be considerable variation in response to treatment; the above dosages may need to be adjusted according to clinical response. Treatment may be repeated every 21 days.
Administer by subcutaneous or intramuscular injection, observing usual aseptic precautions.
Swab the septum before removing each dose. Use a dry sterile needle and syringe and avoid introduction of contamination.
Further information:
The product may be used to continue treatment initiated with similarly acting oral preparations. Such preparations may also be used to continue therapy commenced with this product to allow more rapid termination of treatment if necessary.
Adverse reactions
Long-term use can lead to a change in behavior in very rare cases. This is reversible after stopping treatment. Androgenic side effects can be observed in animals treated with the veterinary medicinal product, in particularly in female animals, in very rare cases.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
